From Name:
From Email:
To Name:
To Email:

Optional Message:

Key safety questions may linger for FDA-expedited drugs

from HealthDay News via U.S. News & World Report

When the U.S. Food and Drug Administration whisks new drugs to market, they do get to patients faster. But they are often not tested as strictly as treatments that get standard reviews, a new study shows. The research suggests that speed may come at the expense of safety when it comes to testing new medications. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063